IGC Pharma (IGC) Interest & Investment Income (2010 - 2017)
IGC Pharma (IGC) reported Interest & Investment Income of $100.0 for Q3 2017, down 12.28% year-over-year from $114.0 in Q3 2016, and down 12.28% quarter-over-quarter from $114.0 in Q3 2016.
IGC Pharma (IGC) Interest & Investment Income (2010 - 2017) Analysis & Trends
IGC Pharma (IGC) has 8 years of Interest & Investment Income data on file, last reported at $100.0 in Q3 2017.
- Interest & Investment Income for Q3 2017 came in at $100.0, down 12.28% year-over-year; the trailing twelve-month figure through Sep 2017 was $2228.0 (up 1.36% YoY), and the FY2017 annual result was $1744.0, down 16.35% from the prior year.
- Interest & Investment Income eased to $100.0 in Q3 2017 per IGC's latest filing, from $114.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $27509.0 in Q1 2013 and troughed at $70.0 in Q4 2015.
- A 5-year average of $3572.3 and a median of $1919.0 in 2013 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2013 and 2015: Interest & Investment Income jumped 387.46% in 2013, then tumbled 95.65% in 2015.
- A 5-year view of Interest & Investment Income shows it stood at $1824.0 in 2013, then slipped by 11.73% to $1610.0 in 2014, then plunged by 95.65% to $70.0 in 2015, then jumped by 62.86% to $114.0 in 2016, then dropped by 12.28% to $100.0 in 2017.
- Business Quant data shows IGC's Interest & Investment Income at $100.0 in Q3 2017, $114.0 in Q3 2016, and $2014.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -14.79 Mn |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 100.00 |
| Sep 30, 2016 | 114.00 |
| Mar 31, 2016 | 2,014.00 |
| Dec 31, 2015 | 70.00 |
| Jun 30, 2015 | 694.00 |
| Mar 31, 2015 | 2,715.00 |
| Dec 31, 2014 | 1,610.00 |
| Sep 30, 2014 | 136.00 |
| Jun 30, 2014 | 2,338.00 |
| Mar 31, 2014 | 4,555.00 |
| Dec 31, 2013 | 1,824.00 |
| Sep 30, 2013 | 2,253.00 |
| Jun 30, 2013 | 4,080.00 |
| Mar 31, 2013 | 27,509.00 |
| Dec 31, 2012 | 2,051.00 |
| Jun 30, 2012 | 837.00 |
| Mar 31, 2012 | 81,131.00 |
| Dec 31, 2011 | 59,629.00 |
| Sep 30, 2011 | 59,085.00 |
| Jun 30, 2011 | 67,348.00 |